Novartis and Transposagen-backed gene and cell therapy developer Poseida Therapeutics closed the series D round two days after filing to go public.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Enterome enters series E stage
Nestlé Health Science and Takeda participated in a series E round for Enterome, which received $52.6m in equity and debt financing through the deal.
Pionyr maps out $1.47bn Gilead deal
Gilead Sciences will invest $275m in return for a 49.9% stake as part of a deal that could see it purchase the cancer immunotherapy developer outright.
GV helps Sana secure $700m
Sana Biotechnology has closed its first round at more than $700m after investors including GV swung behind its vision to commercialise cell therapies.
Somatus creates $64m series C round
The kidney care services provider has now collected more than $105m to date, Optum Ventures co-leading a round also featuring Blue Venture Fund.
Ojo Labs moves into new round
Northwestern Mutual and RBC invested in a $62.5m round for eal estate services platform Ojo that funded the acquisition of Mitsui Fudosan-backed Movoto.
UJet takes off with $55m
GV and Citi Ventures have helped the customer service platform developer nearly double its total funding to $100m by returning for a series C round led by Sapphire Ventures.
Canva designs $60m round
The VaynerMedia-backed online design platform developer was valued at $6bn in a $60m round co-led by Blackbird Ventures and Sequoia China.
Immuta invites corporates to $40m series C
Intel Capital led a $40m round for the data management software provider while Dell Technologies Capital and Citi Ventures also invested.
Cazoo catches funding at billion-dollar valuation
The used car marketplace has achieved unicorn status after raising $31.3m in funding from investors including existing backer DMG Ventures.
Cedar sees its way to $102m
The series C round consisted of $77m in equity funding and $25m in venture debt, with Kaiser Permanente among the participants.
Surrozen scurries to $50m series C
Hartford Healthcare returned for a $50m series C round that will support the Stanford spinout in advancing potential treatments for severe liver and inflammatory bowel diseases.
Payfone picks up $100m
MassMutual Ventures, Synchrony and Blue Venture Fund all returned as the user authentication platform developer almost doubled its overall funding.
Zerto zeroes in on $33m
Access Industries helped supply $33m in equity funding for the cloud management software developer, which also unlocked up to $20m in venture debt financing.